Viking Therapeutics stock rating reiterated at Buy by BTIG on obesity drug progress

Investing.comThursday, October 23, 2025 at 7:42:49 AM
Viking Therapeutics stock rating reiterated at Buy by BTIG on obesity drug progress
Viking Therapeutics has received a positive boost as BTIG has reiterated its Buy rating on the company's stock, highlighting promising progress in its obesity drug development. This endorsement is significant as it reflects confidence in Viking's potential to address a growing health crisis, making it an attractive investment opportunity for those looking to capitalize on advancements in the pharmaceutical sector.
— Curated by the World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended Readings
Deckers Outdoor stock maintains Neutral rating at BTIG amid mixed brand performance
NeutralFinancial Markets
Deckers Outdoor has received a Neutral rating from BTIG, reflecting a mixed performance across its brands. This rating indicates that while some brands are performing well, others are struggling, leading to a cautious outlook for investors. Understanding these dynamics is crucial for stakeholders as they navigate the complexities of the market.
Kyivstar Group stock initiated with Buy rating at BTIG on digital pivot
PositiveFinancial Markets
Kyivstar Group has received a 'Buy' rating from BTIG, signaling strong confidence in the company's digital transformation strategy. This endorsement is significant as it highlights the potential for growth in the digital sector, which is increasingly vital for telecommunications companies. Investors may see this as a promising opportunity, especially as Kyivstar pivots towards more digital services, positioning itself for future success.
Natera stock price target raised to $210 from $200 at BTIG on positive cancer trial data
PositiveFinancial Markets
Natera's stock price target has been raised to $210 from $200 by BTIG, following encouraging data from a recent cancer trial. This increase reflects growing confidence in Natera's potential to make significant advancements in cancer diagnostics, which could lead to better patient outcomes and increased market share for the company. Investors are likely to view this as a positive sign for Natera's future.
H.C. Wainwright maintains Buy rating on Neumora stock ahead of obesity drug data
PositiveFinancial Markets
H.C. Wainwright has reaffirmed its Buy rating on Neumora's stock as anticipation builds for upcoming data on its obesity drug. This is significant because positive results could boost investor confidence and potentially lead to increased market share in the growing obesity treatment sector.
Latest from Financial Markets
Trump sets 10% hike in tariffs on Canada after ad airs during World Series
NegativeFinancial Markets
In a surprising move, President Trump has announced a 10% increase in tariffs on Canadian goods, coinciding with a controversial advertisement that aired during the World Series. This decision is likely to escalate tensions between the two countries and could have significant economic implications, affecting trade relations and prices for consumers. As the situation unfolds, many are left wondering how this will impact the already strained U.S.-Canada relationship.
Trump aims to clinch deal with China’s Xi during Asia trip
PositiveFinancial Markets
During his trip to Asia, Trump is focused on securing a deal with China's President Xi Jinping. This meeting is crucial as it could pave the way for improved trade relations between the two countries, which have been strained in recent years. A successful agreement could benefit both economies and signal a new era of cooperation.
This mysterious billionaire and top Trump backer is behind a $130 million donation to pay troops during the government shutdown, report says
PositiveFinancial Markets
A mysterious billionaire, known for supporting Trump, has made headlines with a remarkable $130 million donation aimed at paying troops during the government shutdown. This significant contribution is crucial as it addresses the financial strain on military personnel caused by the shutdown, highlighting the billionaire's commitment to supporting the armed forces in challenging times. Such actions not only provide immediate relief but also spark discussions about the role of private funding in public services.
Being In an N.B.A. Player’s Entourage Is Fun. Now, It Can Be a Gambling Edge, Too.
PositiveFinancial Markets
Being part of an NBA player's entourage has always been an exciting experience, but now it could also provide a unique advantage in the world of gambling. As the lines between sports and betting continue to blur, insiders are finding that their close relationships with players can offer insights that might influence betting decisions. This trend highlights the evolving landscape of sports betting and raises questions about ethics and fairness in the game.
Exxon sues California over climate disclosure laws
NegativeFinancial Markets
ExxonMobil has filed a lawsuit against California, challenging the state's new climate disclosure laws. This legal action raises significant concerns about transparency and accountability in the oil industry, especially as climate change becomes an increasingly pressing issue. The outcome of this case could set a precedent for how companies disclose their environmental impact, potentially influencing regulations across the country.
British Airways pulls Louis Theroux podcast sponsorship after Bob Vylan interview
NegativeFinancial Markets
British Airways has decided to end its sponsorship of Louis Theroux's podcast following a controversial interview with Bobby Vylan, the lead singer of the band. The airline stated that the interview breached its policy on politically sensitive topics, highlighting the challenges brands face when navigating public discourse. This decision not only impacts the podcast's funding but also raises questions about the limits of corporate sponsorship in creative spaces.